Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables

Clinical trial NCT00698763 · COMPLETED

Trial details

NCT number: NCT00698763
Sponsor: Orion Corporation, Orion Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transient Ischemic Attack Stroke

Start date: 2008-08-01
Primary completion: 2009-04-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.